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Abstract 
This study aimed to estimate the prevalence of cigarette smoking and 
some of the related factors among schizophrenic and other 
hospitalized psychiatric patients. 
Background: 
This was a cross-sectional study on 120 patients hospitalized in Shahid 
Beheshti hospital in Kerman in 2005. Patients were equally devided in 
two groups of schizophrenia and other psychiatric disorders. Sampling 
was based on statistical census and data were collected using a 
questionnaire including 27 questions on demographic data, psychiatric 
disorder, smoking cigarettes and other substances, and Fagerstrom test. 
Data were analyzed by Chi-square and ANOVA tests using SPSS 
software. 
Methods: 
Prevalence and severity of cigarette smoking was 71.6% and 6.47% 
among schizophrenic and 51.6% and 6.40% among other psychiatric 
patients, respectively and the difference was not significant. History of 
withdrawal was 25.6% and 58.1% in the schizophrenia and other disorders 
respectively and the difference was significant (P < 0.05). Addiction to 
other substances was 51.6% in schizophrenic and 45% in the other 
patients and the most prevalent substances in both groups were opium 
and alcohol. The severity of smoking cigarettes was 6.9 along with other 
drug abuses and 5.1 in cases with just smoking based on Fagerstrom test 
and the difference was significant (P < 0.05). 
Findings: 
The prevalence of cigarette smoking in both schizophrenia and other 
psychiatric patients is higher than normal population, but there is no 
significant difference between these two groups. Schizophrenic 
patients need persistent supportive and supervising programs for 
cigarette smoking abuse treatment because of their cognitive, motivate 
and social problems. 
Conclusion: 
Cigarettes, Schizophrenia, Psychiatric disorders Key words: 
6 
2 
0 
26 
Page count: 
Tables: 
Figures: 
References: 
Hasan Ziaaddini, Associate Professor of Psychiatry, School of Medicine, Kerman University 
of Medical Sciences, Kerman, Iran. 
E-mail: h_ziaaddini@yahoo.com 
Address of 
Correspondence: 
Original Article Addiction and Health 
Vol 1, No 1, Summer 2009 
Prevalence of cigarette smoking in schizophrenic… Ziaaddini et al 
Addict & Health, Summer 2009; Vol 1, No 1. 39 
Introduction  
High prevalence of nicotine dependency have 
made it the most common psychiatric disorder.1 
Mortality due to tobacco usage alone is higher 
than mortalities due to suicide, homicide, and 
accidents.2 According to the report of WHO, 
cigarette smoking in the developed countries is 
the cause of 20% of preventable death.3 Studies 
show that smoking cigarettes in psychiatric 
patients especially severe cases is significantly 
high4-7 and patients with worse clinical conditions 
have higher degree of cigarette smoke.8 1.7% of 
population in the US have psychiatric disorders, 
but 34.2% of cigarettes are smoked by these 
group.9 Also, some studies reported a higher rate 
of cigarette smoking in schizophrenic patients 
compared to patients with other psychiatric 
disorders.6 Some other studies found no 
significant difference between cigarette smoking 
among schizophrenia and other psychiatric 
disorders.5 In a study by Leon et al, male 
schizophrenic patients reported to have the 
highest rate of smoking.10 Prevalence and severity 
of smoking determines the severity of psychosis 
symptoms not only in schizophrenia but in other 
psychotic patients such as bipolar psychotic 
patients.11 The amount of smoking in 
schizophrenic patients is reported to be three 
times more than normal population in the US.12 In 
a quantitative study of 42 studies in 20 countries, 
the mean rate of smoking prevalence in 
schizophrenic patients found to be 62%, which 
was significantly higher than normal population.6 
This study showed that schizophrenia and 
cigarette smoking are related and there are 
various ideas explaining this relation. One of 
these hypotheses is that schizophrenia leads to 
smoking because nicotine decreases the disease 
symptoms and most patients use cigarettes for 
self-treatment. Nicotine of the cigarettes affects 
the brain nicotine receivers and reduces 
perception of environmental stimulations 
especially voices and this factor leads to relatively 
decrease of positive symptoms of schizophrenia 
such as hallucinations. 
 Also, by reducing the plasma level of 
antipsychotic drugs, cigarettes nicotine decreases 
the drug side-effects especially that of 
extrapyramidal.13 Another reason for 
schizophrenic patients' smoking is the increase of 
the level of substances such as norepinephrine, 
vazopresin, beta-endorphin, adrenocorticotropic 
hormone and cortisol in blood. These hormones 
are the agents that create the stimulating effects of 
nicotine on brain; and this is why most 
schizophrenics say that smoking makes them 
happy and reduce their depression. Smoking 
affects their ability to control inhibition.14 
 Opposite to these hypotheses, there are other 
groups of hypothesis suggesting that 
schizophrenia happens after smoking. Results of 
the studies in this field are different. Weiser et al 
study15 showed that smoker patients have a 
higher risk of schizophrenia, while study of 
Zammit et al16 reported the effects of smoking to 
be supportive. 
 The results of studies on the relationship 
between smoking and the severity of 
schizophrenia are also controversial. A study 
showed smoking to be associated with both 
positive and negative symptoms of 
schizophrenia17 and other studies found 
relationship just with one of these symptoms;18,19 
some other studies found no relationship with 
any of positive and negative symptoms of 
schizophrenia.20,21 The relationship of smoking 
and depression in schizophrenic patients is also 
determined by retrospective22 and prospective 
studies.23 Schizophrenia can not only increase the 
possibility of smoking but increases the risk of 
severe smoking as well.10 
 In addition to smoking, dependency to other 
drugs is also prevalent among schizophrenic 
patients. In the US, about 30-50% of schizophrenic 
patients are alcoholic and the next prevalence is 
cannabis abuse and cocaine. Association of 
schizophrenia with drug abuse worsens the 
disease signs.12 
 It should be mentioned that smoking 
withdrawal in schizophrenic patients especially 
chronic cases is very difficult due to cognitive and 
social deficits and treatment acceptance also is 
very difficult and even impossible in these 
patients and it can cause a significant increase of 
disabilities and death among them.12 Therefore, 
considering the importance of cigarette abuse in 
health of schizophrenic patients and mentioned 
problems; this study aimed to investigate the 
prevalence and severity of smoking among 
schizophrenic patients hospitalized in psychiatric 
hospitals. 
 
Methods  
This was a descriptive cross-sectional study. The 
study population included patients hospitalized 
in Shahid Beheshti psychiatric hospital of in 
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Kerman, Iran in 2005 who were interviewed in two 
groups, schizophrenia and other psychiatric 
disorders. Diagnoses were approved by two 
psychiatrists and patients who did not have 
schizophrenia in both their clinical and differential 
diagnosis were included in the second group. 
 A total of 120 patients, 80 males and 40 
females were studied. Sampling was census 
method and data were collected using a 
questionnaire with 27 items, completed by 
interviewing patients. The questionnaire included 
demographic data, psychiatric disorder related 
questions (disorder type, hospitalized times), 
smoking related data (started age, amount of 
smoking, withdrawal attempts), and Fagerstrom 
test and dependency to other drugs. Patients 
received explanation on the purpose of the study, 
secrecy of data and the importance of their honest 
replies in advance. 
 Patients whose score was 1-6 in Fagerstrom 
test were ranked as mild to moderate smokers 
and those with 7-11 scores were ranked as heavy 
smokers.25 Data were analyzed using SPSS10 
software by statistical tests of chi-square and 
ANOVA. 
 
Results 
In each group, 40 patients (66.6%) were male and 
20 patients (33.3%) were female. The mean age of 
patients was 30.5 year in schizophrenic and 29 
year in the other group. Psychiatric disorders in 
the other group included bipolar disorder (53.3%, 
32 patients), depression (20%, 12 patients), schizo-
effective (11.7%, 7 patients), personality disorders 
(13.3%, 8 patients), and anxiety disorder (1.7%, 1 
patient). 
 Prevalence of smoking was 71.6% (43 patients) 
in schizophrenic and 51.6% (31 patients) in the 
other group. These patients were smoking 
sometimes or continuously. There was no 
significant difference between prevalence of 
smoking in the two groups (P > 0.05). One patient 
(1.7%) in the schizophrenia and 3 patients (5%) in 
the other group smoked only one time. None of 
the patients succeeded to withdraw smoking 
completely. The mean age of starting smoking 
was 19.1 in schizophrenia and 20.2 in the other 
group. 
 In schizophrenia group the lowest age of 
smoking was 10 and the highest was 31 years of 
age. However, in the other group the youngest 
age of starting to smoke was 9 years of age and 
the oldest was 47 years of age (Table 1). 
 Thirty two schizophrenic patients (74.4%) 
never tried withdrawal and 11 patients (25.6%) 
had a history of withdrawal. In the other group, 
13 patients (41.9%) never tried withdrawal and 18 
patients (58.1%) had a history of withdrawal. 
Among the schizophrenic patients who had a 
history of withdrawal, 5 patients tried 2 to 5 times 
and 6 patients tried 6-10 times. In the other group, 
6 patients tried withdrawal once, 7 patients tried 
2-5 times and 4 patients tried 6-10 times. 
 The patients in both groups mentioned that 
their main reason for withdrawal was because of 
its damage to physical health and after that 
because it is socially unacceptable. To determine 
the severity of smoking, Fagerstrom test was used 
and the results are presented in table 2. The mean 
score of Fagerstrom test was 6.47 in schizophrenia 
(6.8 in male and 5.3 in female) and 6.40 in the 
other group (6.8 in male and 5.2 in female). 
 In schizophrenia group, 31 patients (51.6%) 
were addicted to other substances, 23 of these 
patients were smokers along with other 
addictions, but 4 of them did not smoke 
cigarettes. The commonest drug abused in 
schizophrenia group was opium, opium residue, 
and alcohol and in the other group was opium 
and alcohol. The mean period of addiction to 
these substances was 8.8 years in schizophrenia 
and 10.3 years in the other group. The mean 
scores of Fagerstrom test was 5.1 for patients 
without any associated addiction and it was 6.9 
for those who had associated addiction. This 
difference was highly significant (P < 0.01). The 
mean score of Fagerstrom in schizophrenic 
patients who had associated addiction was 6.8 
while it was 7 for the other group. But the 
difference was not significant (P > 0.05).  
 
Table 1. Age of starting smoking among studied psychiatric patients hospitalized  
 
Age of starting smoking 
Groups 
10-15 
Number(%) 
16-20 
Number(%) 
21-25 
Number(%) 
26-30 
Number(%) 
31-35 
Number(%) 
Schizophrenic patients 13(30.2) 14(32.5) 12(27.9) 3(6.9) 1(2.3) 
Other patients 10(32) 13(41.9) 1(3.2) 3(9.6) 1(3.2) 
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     Table 2. Fagerstrom test results in smoking psychiatric studied patients  
 
 Schizophrenic patients Other patients 
Cigarette dependency 
based on the 
Fagerstrom test scores 
Very low (score = 2) 16.20% 12.90% 
Low (score = 3&4) 23.20% 29% 
Average (score = 5) 13.90% 16.1% 
High (score = 6&7) 13.90% 23.2% 
Very high (score = 8) 23.50% 9.60% 
 
Discussion 
Our findings about of the amount of smoking 
cigarettes among schizophrenic patients was 
similar to the results of studies in other parts of 
the world.5-7,10 Also, this amount was significantly 
higher than the rate in normal population of Iran. 
In the health assessment project conducted in 
1990 in Iran, the rate of smoking in the society 
was 14.6% and in a study by Ministry of Health 
on the Iranian over 20 years of age population, 
21.04% were smoking cigarettes.26 The prevalence 
of cigarette smokers in schizophrenic patients in 
the US is reported to be three times normal 
population.12 Also, in this study the rate of 
cigarette smoke abuse in schizophrenic patients 
showed no significant difference from other 
psychiatric patients, which is reported by other 
studies as well.5 
 Withdrawal attempt among non-
schizophrenic patients was significantly higher 
than schizophrenic patients and it can be related 
to lack of insight and reality assessment ability, 
will, attitude problems, and cognitive and social 
problems of schizophrenics, which make it 
difficult for them to follow withdrawal 
treatments. The severity of smoking based on 
Fagerstrom test showed no significant difference 
between the two groups, even though the scores 
of schizophrenic patients was a little higher. 
 Addiction to other substances showed no 
significant difference in the two groups and the 
severity of smoking also showed no significant 
difference between the drug addicts in the two 
groups. However, the severity of smoking in the 
patients who were both smoking and addicted 
other substances in both groups was higher than 
those who were just smokers. This finding shows 
that severity of smoking is directly related to 
addiction to other substances. 
 In brief, cigarette smoke abuse in psychiatric 
patients is significantly higher than normal 
population. Along with smoking problems in 
these patients, it is important to pay attention to 
addiction to other substances in these patients, 
because addiction to other substances increases 
the severity of smoking and its related 
complications. Due to cognitive, motivative, and 
social problems in schizophrenic patients, treating 
their smoking problems is difficult and constant 
supervision, support and motivating programs 
are necessary to reduce the risks of cigarette 
smoke abuse in these patients. 
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  78/21/2 :ﺗﺎرﻳﺦ درﻳﺎﻓﺖ
  88/2/31 :ﺗﺎرﻳﺦ ﭘﺬﻳﺮش
ﺷﻴﻮع ﻣﺼﺮف ﺳﻴﮕﺎر در ﺑﻴﻤﺎران اﺳﻜﻴﺰوﻓﺮﻧﻲ در ﻣﻘﺎﻳﺴﻪ ﺑﺎ دﻳﮕﺮ 
  ﺑﺴﺘﺮي ﺷﺪه در ﺑﻴﻤﺎرﺳﺘﺎن  ﭘﺰﺷﻜﻲ روانﺑﻴﻤﺎران 
  
  ***دﻛﺘﺮ ﻣﺼﻄﻔﻲ وﻫﺒﻲ ،**دﻛﺘﺮ ﻋﻠﻲ ﺧﺮدﻣﻨﺪ ،*دﻛﺘﺮ ﺣﺴﻦ ﺿﻴﺎء اﻟﺪﻳﻨﻲ
  
*
 .، اﻳﺮانﻛﺮﻣﺎن ،ﻣﺎنداﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮداﻧﺸﻜﺪه ﭘﺰﺷﻜﻲ،  ،ﭘﺰﺷﻜﻲ روانداﻧﺸﻴﺎر ﮔﺮوه  
  .ﻳﺮانان، ﻛﺮﻣﺎ ،داﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﺎنداﻧﺸﻜﺪه ﭘﺰﺷﻜﻲ،  ،ﭘﺰﺷﻜﻲ رواندﺳﺘﻴﺎر  **
***
  .ﻳﺮانان، ﻛﺮﻣﺎداﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ ﻛﺮﻣﺎن، ، ﭘﺰﺷﻚ ﻋﻤﻮﻣﻲ 
  
  :ﻣﻘﺪﻣﻪ
  ﭼﻜﻴﺪه
ﻫﺪف اﻳﻦ  .ﻧﺴﺒﺖ ﺑﻪ ﺟﻤﻌﻴﺖ ﻋﻤﻮﻣﻲ ﺑﺎﻻﺗﺮ اﺳﺖ ﭘﺰﺷﻜﻲ روانﻣﺼﺮف ﺳﻴﮕﺎر در ﺑﻴﻤﺎران ﻣﺒﺘﻼ ﺑﻪ ﺑﻴﻤﺎري 
ﻣﻄﺎﻟﻌﻪ ﺑﺮآورد ﺷﻴﻮع ﻣﺼﺮف ﺳﻴﮕﺎر و ﺑﺮﺧﻲ ﻋﻮاﻣﻞ ﻣﺮﺗﺒﻂ در ﺑﻴﻦ اﻓﺮاد ﻣﺒﺘﻼ ﺑﻪ اﺳﻜﻴﺰوﻓﺮﻧﻲ و دﻳﮕﺮ 
  .ﺑﻮدﺑﺴﺘﺮي در ﺑﻴﻤﺎرﺳﺘﺎن  ﭘﺰﺷﻜﻲ روانﻫﺎي  ﺑﻴﻤﺎري
 06در دو ﮔﺮوه  4831ﺑﻴﻤﺎر ﺑﺴﺘﺮي در ﺑﻴﻤﺎرﺳﺘﺎن ﺷﻬﻴﺪ ﺑﻬﺸﺘﻲ ﻛﺮﻣﺎن در ﺳﺎل  021 ،اﻳﻦ ﭘﮋوﻫﺶ ﻣﻘﻄﻌﻲدر   :ﻫﺎ روش
ﻪ ﮔﻴﺮي ﺑ ﻧﻤﻮﻧﻪ. ﻣﻮرد ﺑﺮرﺳﻲ ﻗﺮار ﮔﺮﻓﺘﻨﺪ ﭘﺰﺷﻜﻲ روانﻫﺎي  ﻓﺮﻧﻲ و ﻣﺒﺘﻼ ﺑﻪ ﺳﺎﻳﺮ ﺑﻴﻤﺎريﻧﻔﺮي ﻣﺒﺘﻼ ﺑﻪ اﺳﻜﻴﺰو
ﺳﺆاﻟﻲ ﺣﺎوي اﻃﻼﻋﺎت دﻣﻮﮔﺮاﻓﻴﻚ،  72ﺻﻮرت ﺳﺮﺷﻤﺎري آﻣﺎري ﺑﻮد و اﻃﻼﻋﺎت از ﻃﺮﻳﻖ ﻳﻚ ﭘﺮﺳﺸﻨﺎﻣﻪ 
ﺮوم و ﺗﺴﺖ ﻓﺎﺟﺮ اﺳﺘ ﻣﺮﺑﻮط ﺑﻪ ﺳﻴﮕﺎر ﻛﺸﻴﺪن و ﻣﺮﺑﻮط ﺑﻪ ﻣﺼﺮف ﺳﺎﻳﺮ ﻣﻮاد ،ﭘﺰﺷﻜﻲ روانﻣﺮﺑﻮط ﺑﻪ ﺑﻴﻤﺎري 
 اﻧﺠﺎم AVONA وﻣﺠﺬور ﻛﺎي  ﻫﺎي آﻣﺎري و آزﻣﻮن  01SSPSاﻓﺰار ﻫﺎ ﺑﺎ ﻛﻤﻚ ﻧﺮم ﺗﺤﻠﻴﻞ داده وآوري  ﺟﻤﻊ
  .ﺷﺪ
ﺑﻮد ﻛﻪ اﺧﺘﻼف % 15/6و در ﮔﺮوه دوم % 17/6ﺷﻴﻮع ﻣﺼﺮف ﺳﻴﮕﺎر در ﺑﻴﻤﺎران اﺳﻜﻴﺰوﻓﺮﻧﻲ ﻣﻌﺎدل   :ﻫﺎ ﻳﺎﻓﺘﻪ
ف ﺳﻴﮕﺎر در ﺑﻴﻤﺎران اﺳﻜﻴﺰوﻓﺮﻧﻲ ﻣﻴﺎﻧﮕﻴﻦ ﺳﻨﻲ ﺷﺮوع ﺑﻪ ﻣﺼﺮ. دﺳﺖ ﻧﻴﺎﻣﺪﻪ ﮔﺮوه ﺑ داري در ﺑﻴﻦ دو ﻣﻌﻨﻲ
و در % 52/6ﺳﺎﺑﻘﻪ اﻗﺪام ﺑﻪ ﺗﺮك ﺑﻪ ﺳﻴﮕﺎر در ﺑﻴﻤﺎران اﺳﻜﻴﺰوﻓﺮﻧﻲ . ﺳﺎل ﺑﻮد02/2و در ﮔﺮوه دوم  91/1
اﺳﺎس ﻧﻤﺮه ﻓﺎﺟﺮ  ﺷﺪت ﻣﺼﺮف ﺳﻴﮕﺎر ﺑﺮ (.< P 0/50) ﺑﻮد دار اﺧﺘﻼف ﻣﻌﻨﻲ و% 85/1ﺑﻴﻤﺎران ﮔﺮوه دوم 
وﺟﻮد  داري ﻣﻌﻨﻲﺑﻮد ﻛﻪ از ﻟﺤﺎظ آﻣﺎري اﺧﺘﻼف  6/04و در ﮔﺮوه دوم  6/74اﺳﺘﺮوم در ﺑﻴﻤﺎران اﺳﻜﻴﺰوﻓﺮﻧﻲ 
ﺑﻪ ﺳﺎﻳﺮ ﻣﻮاد ﻧﻴﺰ اﻋﺘﻴﺎد داﺷﺘﻨﺪ % 54و در ﮔﺮوه دوم % 15/6ﮔﺮوه ﺑﻴﻤﺎران اﺳﻜﻴﺰوﻓﺮﻧﻲ  رد (.> P 0/50)ﻧﺪاﺷﺖ 
در  اﺳﺎس ﻧﻤﺮه ﻓﺎﺟﺮ اﺳﺘﺮوم ﺷﺪت ﻣﺼﺮف ﺳﻴﮕﺎر ﺑﺮ. ﻛﻪ ﺷﺎﻳﻌﺘﺮﻳﻦ اﻳﻦ ﻣﻮاد در ﻫﺮ دو ﮔﺮوه ﺗﺮﻳﺎك و اﻟﻜﻞ ﺑﻮد
دار  ﺑﻮد ﻛﻪ اﺧﺘﻼف ﻣﻌﻨﻲ 5/1و در ﻣﻮارد ﻣﺼﺮف ﺳﻴﮕﺎر ﺑﻪ ﺗﻨﻬﺎﻳﻲ  6/9ﻣﻮارد ﻫﻤﺮاﻫﻲ ﺳﻮء ﻣﺼﺮف ﻣﻮاد دﻳﮕﺮ 
  .ﺑﻮد
ﻧﺴﺒﺖ ﺑﻪ  ﭘﺰﺷﻜﻲ روانﺷﻴﻮع ﺳﻮء ﻣﺼﺮف ﺳﻴﮕﺎر ﻫﻢ در ﺑﻴﻤﺎران اﺳﻜﻴﺰوﻓﺮﻧﻲ و ﻫﻢ در ﺑﻴﻤﺎران دﻳﮕﺮ   :ﮔﻴﺮي ﻧﺘﻴﺠﻪ
در . ﺮوه اﺧﺘﻼف ﻗﺎﺑﻞ ﺗﻮﺟﻬﻲ وﺟﻮد ﻧﺪاردﻃﻮر ﭼﺸﻤﮕﻴﺮي ﺑﺎﻻﺗﺮ اﺳﺖ اﻣﺎ ﺑﻴﻦ اﻳﻦ دو ﮔﻪ ﺟﻤﻌﻴﺖ ﻋﻤﻮﻣﻲ ﺑ
ﺧﺎﻃﺮ ﻪ ﺑ. ﺑﻪ ﻣﻮاد دﻳﮕﺮ از ﺟﻤﻠﻪ ﻣﻮاد ﻣﺨﺪر ﺗﻮﺟﻪ داﺷﺖ ﻛﻨﺎر ﻣﺼﺮف ﺳﻴﮕﺎر ﺑﺎﻳﺪ ﺑﻪ ﺳﻮء ﻣﺼﺮف و اﻋﺘﻴﺎد
ﻣﺸﻜﻼت ﺷﻨﺎﺧﺘﻲ و اﻧﮕﻴﺰﺷﻲ و اﺟﺘﻤﺎﻋﻲ در ﺑﻴﻤﺎران ﻣﺒﺘﻼ ﺑﻪ اﺳﻜﻴﺰوﻓﺮﻧﻲ، درﻣﺎن ﺳﻮء ﻣﺼﺮف ﺳﻴﮕﺎر 
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